FundedIQ
Biotechnology

Pluton Biosciences: Funding, Investors & Team (Sep 2026)

Pluton extracts natural resources from the earth. But the resource we seek is not oil or gas, gold or silver, or even copper or nickel. Their targeted discovery platform "mines"​ microbes from the soil - the bacteria, fungi and viruses that live in and all around us. They call their platform Micromining.

plutonbio.com LinkedIn Saint Louis, United States 1-10 employees
Total raised
$23.1M
Rounds
2
Latest
Series A
May 2023

Pluton Biosciences has raised $23.1M across 2 funding rounds on record, the most recent a Series A of $16.5M announced in May 2023.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Pluton Biosciences Company Profile and Key Stats

Total funding raised
$23.1M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series A
$16.5M in May 2023
Employees
1-10
reported band
Headquarters
Saint Louis, United States

Latest funding round on record: May 2023.

Pluton Biosciences Funding Rounds

Date
Round
Amount
Series A
$16.5M
Seed
$6.6M

Pluton Biosciences raised $6.6M in a Seed announced in Oct 2021.

1.6 years later, a Series A of $16.5M was announced in May 2023.

Pluton Biosciences Founders and Leadership Team

Name
Role
Contact
Elizabeth Gallegos
CEO
Steven Slater
CEO
Locked

Contact details for the Pluton Biosciences team: 1 of 2 have an email address on file.

Start 14-day free trial →

Pluton Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
8,378
$15M

Pluton Biosciences' latest round of $16.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Pluton Biosciences in Biotechnology and Saint Louis

Companies Similar to Pluton Biosciences

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Pluton Biosciences Funding FAQs

What does Pluton Biosciences do?

Pluton extracts natural resources from the earth. But the resource we seek is not oil or gas, gold or silver, or even copper or nickel. Their targeted discovery platform "mines"​ microbes from the soil - the bacteria, fungi and viruses that live in and all around us. They call their platform Micromining.

How much funding has Pluton Biosciences raised?

Pluton Biosciences has raised $23.1M across 2 rounds on record. The most recent is a Series A of $16.5M announced in May 2023.

When did Pluton Biosciences last raise funding?

Pluton Biosciences' most recent funding round on record is a Series A of $16.5M, announced in May 2023.

Who is the CEO of Pluton Biosciences?

Elizabeth Gallegos is listed as CEO at Pluton Biosciences.

Where is Pluton Biosciences headquartered?

Pluton Biosciences is based in Saint Louis, Missouri, United States.

How many employees does Pluton Biosciences have?

Pluton Biosciences is in the 1-10 employee band.

How does Pluton Biosciences' funding compare to other Biotechnology startups?

Pluton Biosciences' latest round of $16.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Pluton Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pluton Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.